ConductScience.org, home

Paper35484110

SARS-CoV-2 Omicron variant: recent progress and future perspectives.

Fan Y and 5 others. Signal Transduct Target Ther, 2022. Cited by 454 papers, by iCite.

Cite this record

ConductScience Library. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Papers, record 35484110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35484110

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SARS-CoV-2 Omicron variant: recent progress and future perspectives.
PubMed
Journal
Signal Transduct Target Ther
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
454
iCite
Relative citation ratio, by iCite
31.1
iCite
Revised in PubMed
2022-12-07
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fan YYao
2Li XXiang
3Zhang LLeihttps://orcid.org/0000-0001-6302-8383
4Wan SShu
5Zhang LLong
6Zhou FFangfanghttps://orcid.org/0000-0003-1870-7584

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
SARS-CoV-2Major topic
Humans
Immunization, Passive
COVID-19 Serotherapy

References126

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134916215Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show.BMJ2021https://conductscience.org/library/papers/34916215PubMed
235086614Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022.Euro Surveill2022https://conductscience.org/library/papers/35086614PubMed
332075877Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.Science2020https://conductscience.org/library/papers/32075877PubMed
435074136
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
Lancet2022https://conductscience.org/library/papers/35074136PubMed
534921135SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34921135PubMed
633158808Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.EBioMedicine2020https://conductscience.org/library/papers/33158808PubMed
735046572mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant.Nat Med2022https://conductscience.org/library/papers/35046572PubMed
835411997Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.Trop Med Int Health2022https://conductscience.org/library/papers/35411997PubMed
933743213Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Cell2021https://conductscience.org/library/papers/33743213PubMed
1032264791Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.Circ Res2020https://conductscience.org/library/papers/32264791PubMed
1135034583Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies.Emerg Microbes Infect2022https://conductscience.org/library/papers/35034583PubMed
1235060999Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.JAMA2022https://conductscience.org/library/papers/35060999PubMed
1335139269Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.N Engl J Med2022https://conductscience.org/library/papers/35139269PubMed
1435026151The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.Cell2022https://conductscience.org/library/papers/35026151PubMed
1535140198ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35140198PubMed
1635149106SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.Environ Res2022https://conductscience.org/library/papers/35149106PubMed
1735081300Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.N Engl J Med2022https://conductscience.org/library/papers/35081300PubMed
1832422645Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.Nature2020https://conductscience.org/library/papers/32422645PubMed
1934075212SARS-CoV-2 variants, spike mutations and immune escape.Nat Rev Microbiol2021https://conductscience.org/library/papers/34075212PubMed
2034915551Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.Clin Infect Dis2022https://conductscience.org/library/papers/34915551PubMed

See all 126 referencesDownload CSV of references

Cited by341

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 454 citations.

PMIDTitleJournalYearIn PapersSource
42707259A viral-vectored multipathogen vaccine platform based on replication-competent vaccinia virus and adeno-associated virus.Front Immunol2026https://conductscience.org/library/papers/42707259PubMed
42549192Impact of SARS-CoV-2 Omicron infection on late pregnancy: an analysis of clinical characteristics, pathology of placenta and outcomes in a case-control study.Open Med (Wars)2026https://conductscience.org/library/papers/42549192PubMed
42419249Biochemical rationale for dietary management of COVID-19 patients: Indian traditional millets as a promising integrative nutritional strategy.J Ayurveda Integr Med2026https://conductscience.org/library/papers/42419249PubMed
42389543Development of bispecific antibodies with enhanced neutralization activity against tested SARS-CoV-2 Omicron subvariants.Front Immunol2026https://conductscience.org/library/papers/42389543PubMed
42334739Genomic surveillance of SARS-CoV-2: a resource-efficient wastewater-based workflow.Mol Biol Rep2026https://conductscience.org/library/papers/42334739PubMed
42318393COVID-19 vaccination in pregnancy: efficacy of second-generation vaccines, maternal-neonatal safety, and strategies to address vaccine hesitancy.Front Med (Lausanne)2026https://conductscience.org/library/papers/42318393PubMed
42316787The pivotal role of β-lactone stereochemistry in the development of SARS-CoV-2 Mpro inhibitors.Protein Sci2026https://conductscience.org/library/papers/42316787PubMed
42291020Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis.J Res Pharm Pract2026https://conductscience.org/library/papers/42291020PubMed
42192199Monitoring viral evolution and epidemiological characteristics of SARS-CoV-2 during 2022-2023 using Integrated Genomic Surveillance.Commun Med (Lond)2026https://conductscience.org/library/papers/42192199PubMed
42116071An intramuscular prime-intranasal boost strategy for mRNA-LNP vaccine induces mucosal immune response against SARS-CoV-2 in murine model.J Transl Med2026https://conductscience.org/library/papers/42116071PubMed
42102110Socioeconomic inequalities and the COVID-19 pandemic in France: Territorial analyzes based on epidemic wave and metropolitan area.PLoS One2026https://conductscience.org/library/papers/42102110PubMed
42094075Epidemiological Trends of COVID-19 Infection and Symptom Incidence in China Following the Adjustment of Zero-COVID Policy: A Prospective, Community-Based Cohort Study.Transbound Emerg Dis2026https://conductscience.org/library/papers/42094075PubMed
42079734Genomic insights into SARS-CoV-2 evolution in Yantai, China after the adjustment of the dynamic zero-COVID policy in 2023.PeerJ2026https://conductscience.org/library/papers/42079734PubMed
42028070Neurocognitive and Psychiatric Outcomes Following Mild to Moderate COVID-19: A Longitudinal Comparison of Alpha/Delta and Omicron Variants.Neuropsychiatr Dis Treat2026https://conductscience.org/library/papers/42028070PubMed
41973264Viral genotype and the pace of epidemic waves: an assessment from SARS-CoV 2 genomics and wastewater surveillance data.Arch Virol2026https://conductscience.org/library/papers/41973264PubMed
41950377Cardiovascular and mortality risks following COVID-19-related versus non-COVID-19-related chronic obstructive pulmonary disease exacerbations.Ann Am Thorac Soc2026https://conductscience.org/library/papers/41950377PubMed
41922730Two years of SARS-CoV-2 genomic surveillance capacity development in Guinea.Sci Rep2026https://conductscience.org/library/papers/41922730PubMed
41826917Critical care trends across five waves of COVID-19 in Pakistan: A multi-center observational study from the Pakistan Registry of Intensive CarE (PRICE).BMC Infect Dis2026https://conductscience.org/library/papers/41826917PubMed
41816409A narrative review of SARS-CoV-2 variants and long COVID.J Thorac Dis2026https://conductscience.org/library/papers/41816409PubMed
41710745Characterization of the Cross-Resistance of SARS-CoV‑2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/41710745PubMed

See all 341 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35484110

GET https://conductscience.org/api/papers/v1/35484110/references?page=2